These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10050987

  • 1. Comparison between fractionated high dose rate irradiation and continuous low dose rate irradiation in spheroids.
    Omura M, Torigoe S, Kurihara H, Matsubara S, Kubota N.
    Acta Oncol; 1998; 37(7-8):681-6. PubMed ID: 10050987
    [Abstract] [Full Text] [Related]

  • 2. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P, Schneider CJ, Fowler JF.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):844-9. PubMed ID: 11849810
    [Abstract] [Full Text] [Related]

  • 3. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation.
    Veninga T, Visser AG, van den Berg AP, van Hooije CM, van Geel CA, Levendag PC.
    Int J Radiat Oncol Biol Phys; 2001 Apr 01; 49(5):1351-60. PubMed ID: 11286843
    [Abstract] [Full Text] [Related]

  • 4. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S, Trisler K, Wessels BW, Knox SJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [Abstract] [Full Text] [Related]

  • 5. [In vitro studies of PDR brachytherapy].
    Fritz P, Frank C, Weber KJ.
    Strahlenther Onkol; 1998 Jul 15; 174(7):365-74. PubMed ID: 9689958
    [Abstract] [Full Text] [Related]

  • 6. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
    King CR.
    Brachytherapy; 2002 Jul 15; 1(4):219-26. PubMed ID: 15062170
    [Abstract] [Full Text] [Related]

  • 7. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells.
    Orton CG.
    Int J Radiat Oncol Biol Phys; 2001 Jan 01; 49(1):183-9. PubMed ID: 11163513
    [Abstract] [Full Text] [Related]

  • 8. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
    Visser AG, van den Aardweg GJ, Levendag PC.
    Int J Radiat Oncol Biol Phys; 1996 Jan 15; 34(2):497-505. PubMed ID: 8567354
    [Abstract] [Full Text] [Related]

  • 9. [The dosage-performance effects on Ca-Ski and HPK cells in relation to the dose and fractionation].
    Schulz-Wendtland R, Krämer S, Keilholz L, Pflüger S, Lang N.
    Strahlenther Onkol; 1996 Aug 15; 172(8):439-45. PubMed ID: 8765347
    [Abstract] [Full Text] [Related]

  • 10. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
    Levendag PC, Schmitz PI, Jansen PP, Senan S, Eijkenboom WM, Sipkema D, Meeuwis CA, Kolkman-Deurloo IK, Visser AG.
    Int J Radiat Oncol Biol Phys; 1997 Jun 01; 38(3):497-506. PubMed ID: 9231672
    [Abstract] [Full Text] [Related]

  • 11. Influence of dose-rate, post-irradiation incubation time and growth factors on interphase cell death by apoptosis and clonogenic survival of human peripheral lymphocytes.
    Meijer AE, Saeidi AB, Zelenskaya A, Czene S, Granath F, Harms-Ringdahl M.
    Int J Radiat Biol; 1999 Oct 01; 75(10):1265-73. PubMed ID: 10549603
    [Abstract] [Full Text] [Related]

  • 12. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E, Oh RJ, Yamada Y, Shiomi H, Nakamura S, Shimamoto S, Teshima T, Inoue T, Inoue T.
    Brachytherapy; 2003 Oct 01; 2(2):85-90. PubMed ID: 15062145
    [Abstract] [Full Text] [Related]

  • 13. The irradiation tolerance dose of the proximal vagina.
    Au SP, Grigsby PW.
    Radiother Oncol; 2003 Apr 01; 67(1):77-85. PubMed ID: 12758243
    [Abstract] [Full Text] [Related]

  • 14. Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose.
    Manimaran S.
    Radiat Med; 2007 Jun 01; 25(5):229-35. PubMed ID: 17581712
    [Abstract] [Full Text] [Related]

  • 15. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC, Kim GE, Suh CO, Loh JJ.
    Jpn J Clin Oncol; 2001 Sep 01; 31(9):432-7. PubMed ID: 11689597
    [Abstract] [Full Text] [Related]

  • 16. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas.
    Yuan X, Dillehay LE, Williams JR, Shastri VR, Williams JA.
    Int J Cancer; 2001 Apr 20; 96(2):118-25. PubMed ID: 11291095
    [Abstract] [Full Text] [Related]

  • 17. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
    Pop LA, Millar WT, Visser AG, van der Kogel AJ.
    Int J Radiat Oncol Biol Phys; 2001 Sep 01; 51(1):215-26. PubMed ID: 11516872
    [Abstract] [Full Text] [Related]

  • 18. Inverse dose-rate-effects on the expressions of extra-cellular matrix-related genes in low-dose-rate gamma-ray irradiated murine cells.
    Sugihara T, Murano H, Tanaka K, Oghiso Y.
    J Radiat Res; 2008 May 01; 49(3):231-40. PubMed ID: 18285661
    [Abstract] [Full Text] [Related]

  • 19. Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: a nonrandomized comparison of treatment results.
    Hsu WL, Wu CJ, Jen YM, Yen SH, Lin KT, Ger LP, Kim RY.
    Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1425-31. PubMed ID: 7635783
    [Abstract] [Full Text] [Related]

  • 20. High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix.
    Kagei K, Shirato H, Nishioka T, Kitahara T, Suzuki K, Tomita M, Takamura A, Arimoto T, Matsuoka S, Mizoe JE, Sakuragi N, Fujimoto S, Miyasaka K.
    Radiother Oncol; 1998 May 30; 47(2):207-13. PubMed ID: 9683371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.